Skip to main content
IMBRUVICA™ Approved For Previously Treated Chronic Lymphocytic Leukemia; Immediately Available Through Onco360®
Read More
Mekinist™ (trametinib) & Tafinlar® (dabrafenib) Approved In Combination; Both Limited Distribution Products Immediately Available Via Onco360®
Read More
FDA Updates
Omacetaxine Mepesuccinate: A Novel mRNA Translation Inhibitor for Drug-Resistant Chronic Myelogenous Leukemia
Jacqueline L. Olin, MS, PharmD, BCPS, Sabrina W. Cole, PharmD, BCPS, Amie J. Dirks-Naylor, PhD
Read More
FDA Updates
Recent Cancer Drugs Approved by the FDA
Read More
Original Research
The Impact of Angiotensin II Receptor Blocker Use in Patients with Prostate Cancer
Lisa Cerutti, PharmD, Jacob K. Kettle, PharmD, BCOP, Dennis W. Grauer, MS, PhD
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
PharMerica and Onco360 Finalize Strategic Investment; Establish First National Oncology Pharmacy and Care Management Platform
Read More
Supplements
Introduction to the Resident Reporter Program: Part 2
Patrick J. Medina, PharmD, BCOP, FHOPA
Read More
Highlights from Key Meetings in Hematology and Oncology
Brian Dinh, PharmD, Lisa A. Raedler, PhD, RPh, Medical Writer
Read More
Practical Issues in Pharmacy Management
Financial Savings from On-Site Dispensing of Oral Chemotherapies
Adam Kramer, PharmD, Colleen Powell, CPhT
Read More
Page 183 of 196
Results 1821 - 1830 of 1955